• Building Biotechs
  • Posts
  • Building Biotechs Better: Inside LabCentral's Culture of Innovation

Building Biotechs Better: Inside LabCentral's Culture of Innovation

Plus AgBio Boom, Will the Fed's rate cut spur biotech funding? And more!

Author

Carina Clingman
September 25, 2024

Happy Wednesday!

For the next few weeks, I’m focusing on tools and resources for startups. I have some great interviews on the podcast, starting with resurfacing a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral.

If you're in the MA area, you're probably familiar with the organization. Mike breaks down how a startup ecosystem can benefit growing companies, from access to funding to parties and social events to boost morale.

Community is central to LabCentral's mission, and Mike explains why the biotechs love it there. Listen in, and I’ll see you at the next LabCentral party!

What’s inside:

  • PODCAST EPISODE: Building Biotechs Better: Inside LabCentral's Culture of Innovation

  • CAREER CORNER: Evaluating Job Security in a Tough Biopharma Market

  • BIOTECH NEWS: AgBio is booming, What the Fed’s rate cut might do for biotech funding, AI, funding wins, and more layoffs.

The Building Biotechs Podcast

Building Biotechs Better: Inside LabCentral's Culture of Innovation with Mike LaRhette, Chief Business Officer

In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral. Mike offers insights into the key elements that make thriving ecosystems, like government support, industry collaboration, and a density of entrepreneurs. He also discusses how LabCentral supports startups through challenging markets, diverse talent acquisition, and successful graduations. The episode concludes with a lighthearted look at LabCentral's unique culture and the balance between hard work and fun.

Career Corner

Evaluating Job Security in a Tough Biopharma Market

Job security is a hot topic among biopharma professionals. Carina Clingman, PhD, offers advice on evaluating potential opportunities and what to do if that evaluation leaves you worried.

Need New HRIS/Payroll Software? Help Is on the Way!

  • Get a tailored vendor shortlist based on your unique needs

  • Personalized 1:1 help from an HR software expert

  • Save time and money with expert research

  • Access to HR tool pricing insights

  • No fees, no commitments

Stories We’re Following

Agricultural Biotechnology Market Hits $232 Billion By 2033

Agricultural Biotechnology Market Size is expected to reach USD 232 Bn by 2033, from USD 111 Bn in 2023, growing at a CAGR of 7.86%.

Can the Fed’s rate cut change biotech’s ‘new normal’?

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

The Week’s 10 Biggest Funding Rounds: Greentech And Biotech See $200M Raises

A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course, biotech and fintech were in there too.

The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present

Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them. From the benefits included in advancing processes to cybersecurity hazards, AI innovation is a balanced scale of oppportunities and risks.

Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News

Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.

Did someone forward this to you? Wow, you have great friends! Join Our Newsletter to Stay Plugged In.